Septerna (SEPN) Revenue (2023 - 2026)

Septerna's (SEPN) quarterly Revenue came in at $26.5 million in Q1 2026, up 12000.46% year-on-year from N/an in Q1 2025, and up 9.88% quarter-over-quarter from $24.1 million in Q4 2025.

Septerna (SEPN) Revenue (2023 - 2026) Analysis & Trends

Septerna's Revenue history runs 4 years deep, the most recent figure standing at $26.5 million for Q1 2026.

  • On a quarterly basis, Revenue rose 12000.46% year-over-year to $26.5 million in Q1 2026; TTM through Mar 2026 was $72.2 million, a 7293.24% increase from a year earlier, with the FY2025 full-year figure at $46.0 million, up 4174.51% from the prior year.
  • Revenue grew to $26.5 million in Q1 2026 per SEPN's latest filing, from $24.1 million in the prior quarter.
  • Across five years, Revenue topped out at $26.5 million in Q1 2026 and bottomed at $33000.0 in Q3 2023.
  • The 4-year median for Revenue is $219000.0 (2025), against an average of $6.7 million.
  • Biggest YoY gain for Revenue was 12113.07% in 2025; the steepest drop was 67.84% in 2025.
  • Year by year, Revenue stood at $118000.0 in 2023, then surged by 79.66% to $212000.0 in 2024, then jumped by 11276.42% to $24.1 million in 2025, then gained by 9.88% to $26.5 million in 2026.
  • Per Business Quant, the three latest SEPN Revenue figures stand at $26.5 million (Q1 2026), $24.1 million (Q4 2025), and $21.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 1.30 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Septerna 1.48 Bn 1.48 Bn - 26.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 26.50 Mn
Dec 31, 2025 24.12 Mn
Sep 30, 2025 21.50 Mn
Jun 30, 2025 119,000.00
Mar 31, 2025 219,000.00
Dec 31, 2024 212,000.00
Sep 30, 2024 176,000.00
Jun 30, 2024 370,000.00
Mar 31, 2024 317,000.00
Dec 31, 2023 118,000.00
Sep 30, 2023 33,000.00